454 related articles for article (PubMed ID: 31451630)
1. Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study.
Rastinehad AR; Anastos H; Wajswol E; Winoker JS; Sfakianos JP; Doppalapudi SK; Carrick MR; Knauer CJ; Taouli B; Lewis SC; Tewari AK; Schwartz JA; Canfield SE; George AK; West JL; Halas NJ
Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18590-18596. PubMed ID: 31451630
[TBL] [Abstract][Full Text] [Related]
2. Focal Laser Ablation of Prostate Cancer: Feasibility of Magnetic Resonance Imaging-Ultrasound Fusion for Guidance.
Natarajan S; Jones TA; Priester AM; Geoghegan R; Lieu P; Delfin M; Felker E; Margolis DJA; Sisk A; Pantuck A; Grundfest W; Marks LS
J Urol; 2017 Oct; 198(4):839-847. PubMed ID: 28396184
[TBL] [Abstract][Full Text] [Related]
3. Phase II Evaluation of Magnetic Resonance Imaging Guided Focal Laser Ablation of Prostate Cancer.
Eggener SE; Yousuf A; Watson S; Wang S; Oto A
J Urol; 2016 Dec; 196(6):1670-1675. PubMed ID: 27449263
[TBL] [Abstract][Full Text] [Related]
4. Focal Laser Ablation of Prostate Cancer: Phase I Clinical Trial.
Natarajan S; Raman S; Priester AM; Garritano J; Margolis DJ; Lieu P; Macairan ML; Huang J; Grundfest W; Marks LS
J Urol; 2016 Jul; 196(1):68-75. PubMed ID: 26748164
[TBL] [Abstract][Full Text] [Related]
5. Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy.
Mannaerts CK; Gayet M; Verbeek JF; Engelbrecht MRW; Savci-Heijink CD; Jager GJ; Gielens MPM; van der Linden H; Beerlage HP; de Reijke TM; Wijkstra H; Roobol MJ
Eur Urol Oncol; 2018 Jun; 1(2):109-117. PubMed ID: 31100233
[TBL] [Abstract][Full Text] [Related]
6. Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissue in Patients with Localized Prostate Cancer: A Prospective Phase 1 Clinical Trial.
Chin JL; Billia M; Relle J; Roethke MC; Popeneciu IV; Kuru TH; Hatiboglu G; Mueller-Wolf MB; Motsch J; Romagnoli C; Kassam Z; Harle CC; Hafron J; Nandalur KR; Chronik BA; Burtnyk M; Schlemmer HP; Pahernik S
Eur Urol; 2016 Sep; 70(3):447-55. PubMed ID: 26777228
[TBL] [Abstract][Full Text] [Related]
7. 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.
Piert M; Montgomery J; Kunju LP; Siddiqui J; Rogers V; Rajendiran T; Johnson TD; Shao X; Davenport MS
J Nucl Med; 2016 Jul; 57(7):1065-70. PubMed ID: 26985061
[TBL] [Abstract][Full Text] [Related]
8. Comparison of complications rates between multiparametric magnetic resonance imaging-transrectal ultrasound (TRUS) fusion and systematic TRUS prostatic biopsies.
Queiroz MRG; Falsarella PM; Mariotti GC; Lemos GC; Baroni RH; Mussi TC; Garcia RG
Abdom Radiol (NY); 2019 Feb; 44(2):732-738. PubMed ID: 30255444
[TBL] [Abstract][Full Text] [Related]
9. Two-year Outcomes Following Focal Laser Ablation of Localized Prostate Cancer.
Chao B; Llukani E; Lepor H
Eur Urol Oncol; 2018 Jun; 1(2):129-133. PubMed ID: 31100236
[TBL] [Abstract][Full Text] [Related]
10. MR imaging-guided focal laser ablation for prostate cancer: phase I trial.
Oto A; Sethi I; Karczmar G; McNichols R; Ivancevic MK; Stadler WM; Watson S; Eggener S
Radiology; 2013 Jun; 267(3):932-40. PubMed ID: 23440319
[TBL] [Abstract][Full Text] [Related]
11. Detection of significant prostate cancer with magnetic resonance targeted biopsies--should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care?
Delongchamps NB; Lefèvre A; Bouazza N; Beuvon F; Legman P; Cornud F
J Urol; 2015 Apr; 193(4):1198-204. PubMed ID: 25451824
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance.
Radtke JP; Kuru TH; Boxler S; Alt CD; Popeneciu IV; Huettenbrink C; Klein T; Steinemann S; Bergstraesser C; Roethke M; Roth W; Schlemmer HP; Hohenfellner M; Hadaschik BA
J Urol; 2015 Jan; 193(1):87-94. PubMed ID: 25079939
[TBL] [Abstract][Full Text] [Related]
13. Biochemical and magnetic resonance image response in targeted focal cryotherapy to ablate targeted biopsy-proven index lesion of prostate cancer.
Inoue Y; Ushijima S; Shiraishi T; Fujihara A; Hongo F; Ukimura O
Int J Urol; 2019 Feb; 26(2):317-319. PubMed ID: 30485553
[No Abstract] [Full Text] [Related]
14. Safety and Feasibility of Direct Magnetic Resonance Imaging-guided Transperineal Prostate Biopsy Using a Novel Magnetic Resonance Imaging-safe Robotic Device.
Ball MW; Ross AE; Ghabili K; Kim C; Jun C; Petrisor D; Pan L; Epstein JI; Macura KJ; Stoianovici DS; Allaf ME
Urology; 2017 Nov; 109():216-221. PubMed ID: 28735018
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome Wide Analysis of Magnetic Resonance Imaging-targeted Biopsy and Matching Surgical Specimens from High-risk Prostate Cancer Patients Treated with Radical Prostatectomy: The Target Must Be Hit.
Radtke JP; Takhar M; Bonekamp D; Kesch C; Erho N; du Plessis M; Buerki C; Ong K; Davicioni E; Hohenfellner M; Hadaschik BA
Eur Urol Focus; 2018 Jul; 4(4):540-546. PubMed ID: 28753844
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies.
Filson CP; Natarajan S; Margolis DJ; Huang J; Lieu P; Dorey FJ; Reiter RE; Marks LS
Cancer; 2016 Mar; 122(6):884-92. PubMed ID: 26749141
[TBL] [Abstract][Full Text] [Related]
17. Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy of the Prostate-An Update.
Das CJ; Razik A; Sharma S
Semin Roentgenol; 2018 Jul; 53(3):219-226. PubMed ID: 30031415
[No Abstract] [Full Text] [Related]
18. Multiparametric ultrasound-targeted biopsy compares favorably to multiparametric MRI-transrectal ultrasound fusion-targeted biopsy on initial biopsy of men at risk for prostate cancer.
Fulgham PF
World J Urol; 2018 May; 36(5):713-718. PubMed ID: 29368230
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging-ultrasound fusion guided focal cryoablation for men with intermediate-risk prostate cancer.
Sidana A; Tayebi S; Blank F; Lama DJ; Meyer M; Saeed Y; Tobler J; Hsu WW; Verma S
Urol Oncol; 2024 May; 42(5):158.e1-158.e10. PubMed ID: 38245407
[TBL] [Abstract][Full Text] [Related]
20. An initial negative round of targeted biopsies in men with highly suspicious multiparametric magnetic resonance findings does not exclude clinically significant prostate cancer-Preliminary experience.
Costa DN; Kay FU; Pedrosa I; Kolski L; Lotan Y; Roehrborn CG; Hornberger B; Xi Y; Francis F; Rofsky NM
Urol Oncol; 2017 Apr; 35(4):149.e15-149.e21. PubMed ID: 27939349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
